27 April 2017 (Thursday) - The Oncologist

I've signed up to "The Oncologist" - a free e-newsletter. One arrived today:

The BALLET Study: Italian Cohort Subset Analysis

Daniele Generali et al.

 

The BALLET study was a European open‐label, multicenter, expanded access study designed to allow treatment with everolimus plus exemestane in postmenopausal women with hormone receptor‐positive metastatic breast cancer progressed following prior endocrine therapy. This article evaluates whether previous chemotherapy in the metastatic setting affects the safety profile of the combination regimen of everolimus and exemestane was conducted on the Italian subset.

 

In the News   Experimental Drug Could Lead to Potent Combination in Breast and Other Cancers   Why Latest Work from Top UK Cancer Researchers Could Hold Potential for Future ‘Game-Changing’ Treatments for Rare Bile Duct Cancer, Cholangiocarcinoma   Targeting Cancer Spread: Keeping Breast Tumours Under LOX and Key

CME Activities   Management of Cancer in the Older Age Person: An Approach to Complex Medical Decisions     Multidisciplinary Management of Breast Cancer During Pregnancy ADVERTISEMENT

Genomics of a Mitochondria-Rich Tumor   From the most recent Chabner Colloquium and STO Annual Meeting Raj Gopal, MD, PhD, Massachusetts General Hospital, Harvard Medical School discussed how researchers focused on simultaneous analysis of both mitochondrial DNA (mtDNA) and nuclear DNA (nuDNA) for somatic events that may contribute to oncocytic cellular change to learn more about the role of mitochondrial metabolism in tumors. Watch Now >